FDA HAS ASSIGNED RMAT STATUS TO RETT SYNDROME GENE THERAPY
.
Saved in:
Main Author: | article Editorial (Author) |
---|---|
Format: | Book |
Published: |
Union of pediatricians of Russia,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023) -
The FDA has approved the first gene therapy for the treatment of Duchennel's muscular dystrophy
by: article Editorial
Published: (2023) -
THE FDA HAS APPROVED TWO GENE THERAPY DRUGS FOR THE TREATMENT OF SICKLE CELL ANEMIA
by: article Editorial
Published: (2024) -
FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN
by: article Editorial
Published: (2024) -
The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023)